Sacituzumab Tirumotecan Approval in China By
December 16, 2024 05:19 ET
|
KuicK Research
Delhi, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The recent approval of sacituzumab tirumotecan in China represents a significant advancement in oncology, particularly in the realm of targeted therapies....
Targeted Alpha Therapy Market 2028
December 12, 2024 12:55 ET
|
KuicK Research
Delhi, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights: Global Targeted...
GCC Pharmaceutical Market To Surpass USD 12 Billion Opportunity By 2030
December 05, 2024 05:30 ET
|
KuicK Research
Delhi, Dec. 05, 2024 (GLOBE NEWSWIRE) -- GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 Report Highlights: GCC Pharmaceutical Market Opportunity: > US$ 12 Billion By ...
US FDA Grants Approval For Zanidatamab Ziihera Bispecific Antibody For Biliary Tract Cancer
November 25, 2024 05:47 ET
|
KuicK Research
Delhi, Nov. 25, 2024 (GLOBE NEWSWIRE) -- In November 2024, Jazz Pharmaceuticals announced that the US FDA granted accelerated approval for zanidatamab, a bispecific antibody, for the treatment of...
Global Cancer Peptide Drugs Market Cancer Peptide Therapeutics Clinical Trials Market Forecast 2030
November 25, 2024 05:47 ET
|
KuicK Research
Delhi, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: Global Peptide Cancer Drug Market...
Global Cancer Antibody Drug Conjugates Market Size Forecast 2030
October 22, 2024 14:33 ET
|
KuicK Research
Delhi, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions: Global...
Global PROTAC Therapy Market Clinical Trials Drug Approval Insight
October 14, 2024 08:06 ET
|
KuicK Research
Delhi, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027 Report Finding & Inclusions: First PROTAC Drug...
Proteolysis Targeting Chimeras PROTAC Therapy For Lung Cancer
October 11, 2024 06:42 ET
|
KuicK Research
Delhi, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Global Proteolysis Targeting Chimeras PROTAC Therapy Clinical Trials Insight & Market Opportunity Report Highlights: First PROTAC Drug Approval Expected...
Global Proteolysis Targeting Chimeras PROTAC Targeted Protein Degradation Therapy Clinical Trials Insight
October 10, 2024 06:07 ET
|
KuicK Research
Delhi, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Global Proteolysis Targeting Chimeras PROTAC Therapy Clinical Trials Insight & Market Opportunity Report Highlights: First PROTAC Drug Approval...
Global Bispecific Antibody Market Size Bispecific Antibodies Sales FDA Approved Bispecific Antibodies Market Forecast
October 04, 2024 07:34 ET
|
KuicK Research
Delhi, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development...